Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$314.42 - $351.91 $40,874 - $45,748
-130 Reduced 1.77%
7,205 $2.54 Million
Q1 2023

May 12, 2023

BUY
$283.23 - $323.1 $41,634 - $47,495
147 Added 2.05%
7,335 $2.31 Million
Q4 2022

Feb 14, 2023

BUY
$285.76 - $321.48 $56,294 - $63,331
197 Added 2.82%
7,188 $2.08 Million
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $2,464 - $2,749
9 Added 0.13%
6,991 $2.02 Million
Q2 2022

Aug 15, 2022

BUY
$234.96 - $292.55 $90,224 - $112,339
384 Added 5.82%
6,982 $1.97 Million
Q1 2022

May 11, 2022

BUY
$221.42 - $260.97 $38,305 - $45,147
173 Added 2.69%
6,598 $1.72 Million
Q4 2021

Feb 14, 2022

SELL
$177.01 - $223.45 $56,112 - $70,833
-317 Reduced 4.7%
6,425 $1.41 Million
Q3 2021

Nov 15, 2021

SELL
$181.39 - $202.99 $22,673 - $25,373
-125 Reduced 1.82%
6,742 $1.22 Million
Q2 2021

Aug 16, 2021

BUY
$187.49 - $221.1 $9,561 - $11,276
51 Added 0.75%
6,867 $1.39 Million
Q1 2021

May 17, 2021

BUY
$207.02 - $241.31 $145,328 - $169,399
702 Added 11.48%
6,816 $1.47 Million
Q4 2020

Feb 11, 2021

SELL
$207.01 - $276.09 $102,469 - $136,664
-495 Reduced 7.49%
6,114 $1.45 Million
Q3 2020

Nov 13, 2020

SELL
$255.65 - $303.1 $11,248 - $13,336
-44 Reduced 0.66%
6,609 $1.8 Million
Q2 2020

Aug 14, 2020

SELL
$225.48 - $295.8 $146,111 - $191,678
-648 Reduced 8.88%
6,653 $1.93 Million
Q1 2020

May 13, 2020

SELL
$199.77 - $247.81 $6,192 - $7,682
-31 Reduced 0.42%
7,301 $1.74 Million
Q4 2019

Feb 14, 2020

BUY
$166.71 - $223.91 $23,839 - $32,019
143 Added 1.99%
7,332 $1.61 Million
Q3 2019

Nov 12, 2019

BUY
$166.23 - $187.09 $12,633 - $14,218
76 Added 1.07%
7,189 $1.22 Million
Q2 2019

Aug 12, 2019

SELL
$164.61 - $190.37 $9,876 - $11,422
-60 Reduced 0.84%
7,113 $1.3 Million
Q1 2019

May 15, 2019

BUY
$163.73 - $194.7 $29,962 - $35,630
183 Added 2.62%
7,173 $1.32 Million
Q4 2018

Feb 14, 2019

SELL
$151.91 - $192.21 $46,028 - $58,239
-303 Reduced 4.15%
6,990 $1.16 Million
Q3 2018

Nov 14, 2018

BUY
$167.73 - $192.74 $69,104 - $79,408
412 Added 5.99%
7,293 $1.41 Million
Q2 2018

Aug 13, 2018

BUY
$145.72 - $169.96 $66,302 - $77,331
455 Added 7.08%
6,881 $1.17 Million
Q1 2018

May 14, 2018

BUY
$151.6 - $177.13 $50,028 - $58,452
330 Added 5.41%
6,426 $1.05 Million
Q4 2017

Feb 13, 2018

SELL
$137.28 - $155.55 $38,438 - $43,554
-280 Reduced 4.39%
6,096 $914,000
Q3 2017

Nov 14, 2017

BUY
$148.13 - $162.24 $944,476 - $1.03 Million
6,376
6,376 $969,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $133B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Veritable, L.P. Portfolio

Follow Veritable, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Veritable, L.P. with notifications on news.